Fred Alger Management, LLC Eli Lilly & CO Transaction History

Fred Alger Management, LLC

$20.1 Billion
Q2 2024

A detailed history of Fred Alger Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fred Alger Management, LLC holds 277,834 shares of LLY stock, worth $244 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

277,834

Previous 323,989 14.25%

Holding current value

$244 Million

Previous $252 Million 0.2%

% of portfolio

1.25%

Previous 1.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $33.5 Million - $42 Million	-46,155 Reduced 14.25%	277,834 $252 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $24.1 Million - $32.2 Million	40,617 Added 14.33%	323,989 $252 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $27.4 Million - $32.3 Million	52,243 Added 22.6%	283,372 $165 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $37.9 Million - $52.2 Million	87,164 Added 60.55%	231,129 $124 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $19.4 Million - $26 Million	55,441 Added 62.63%	143,965 $67.5 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $144 Million - $169 Million	-463,367 Reduced 83.96%	88,524 $30.4 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $17.6 Million - $20.5 Million	54,635 Added 10.99%	551,891 $202 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $134 Million - $152 Million	451,041 Added 975.96%	497,256 $161 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.78 Million - $2.09 Million	6,384 Added 16.03%	46,215 $15 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $95,284 - $118,413	406 Added 1.03%	39,831 $11.4 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $14.8 Million - $18.3 Million	-65,680 Reduced 62.49%	39,425 $10.9 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $11.2 Million - $13.8 Million	-50,467 Reduced 32.44%	105,105 $24.3 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $22.5 Million - $29.2 Million	124,856 Added 406.49%	155,572 $35.7 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $117,653 - $152,307	716 Added 2.39%	30,716 $5.74 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $5.29 Million - $7 Million	-40,521 Reduced 57.46%	30,000 $5.07 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $3.56 Million - $4.11 Million	-24,328 Reduced 25.65%	70,521 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $1.6 Million - $1.92 Million	11,705 Added 14.08%	94,849 $15.6 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $6.72 Million - $8.32 Million	56,431 Added 211.25%	83,144 $11.5 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $1.27 Million - $1.57 Million	11,880 Added 80.09%	26,713 $3.51 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $3.79 Million - $4.12 Million	-35,494 Reduced 70.53%	14,833 $1.66 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $5.56 Million - $6.49 Million	-50,199 Reduced 49.94%	50,327 $5.58 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $1.11 Million - $1.31 Million	9,998 Added 11.04%	100,526 $13 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $3.02 Million - $3.38 Million	28,527 Added 46.01%	90,528 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $2.58 Million - $3.22 Million	30,000 Added 93.75%	62,001 $6.65 Million
Q2 2018 Jul 19, 2018	SELL	$75.7 - $86.88 $43,376 - $49,782	-573 Reduced 1.76%	32,001 $2.73 Million
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $1.55 Million - $1.83 Million	-20,862 Reduced 39.04%	32,574 $2.52 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $294,000 - $315,349	-3,588 Reduced 6.29%	53,436 $4.51 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $4.39 Million - $4.88 Million	57,024	57,024 $4.88 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Eli Lilly & CO Transaction History